6550--INTENT TO SOLE SOURCE - Buffalo VA Thermo Fisher GENEXUS Reagents

Both instruments are owned and operated by the Buffalo VAMC Pathology and Laboratory Medicine department. The Genexus instrument utilizes the Oncomine Precision Assay which enables simultaneous detection of biomarkers across 50 genes, including key targets within EGFR, BRAF, KRAS, ALK, ROS1, NTRK, RET, HER2, and others, from solid tissue samples. Genomic profiling of tumors from cancer patients facilitates molecular-guided therapy. The OPA NGS panel has significant clinical utility in cancer treatment by providing comprehensive genomic profiling of a tumor sample, allowing healthcare providers to identify actionable genetic alterations and select the most appropriate targeted therapies for a patient based on their specific tumor mutations, leading to more effective treatment plans. Item number Description Quantity A40261 Ion Torrent Genexus Barcodes 1-32- AS HD 12 A40266 Ion Torrent Genexus Pipette tips 7 4483354 96-well plates (20/box) 4 A40269 Ion Torrent GX5 Chip and Genexus Coupler 6 A40271 Genexus Sequencing Kit 6 AB0626 Adhesive Foil Seals Microp Lates oe PCR Plates 1 A40263 Genexus Templating Strips 3 and 4-GX5 (8/BOX) 7 A45539 Genexus� FFPE DNA/RNA Purification Kit 6 A46291 Oncomine Precision Assay GX 12 This notice is being published in accordance with Federal Acquisition Regulation (FAR) Subpart 5.101 requiring dissemination of information for proposed contract actions. This is a notice of intent to award a sole source contract and is not a request for competitive quotes/proposals. The statutory authority for this sole source procurement is prescribed by FAR 13.105(a). The Department of Veterans Affairs, Buffalo, NY location intends to issue a sole source award contract to Thermo Fisher Scientific, all responsible sources may submit a capability statement demonstrating the ability to provide the requested services, which shall be considered by the agency before the intended award date. The Government shall not reimburse interested sources for any information provided. No requests for capability briefings will be honored. NAICS Code: 325413 In-Vitro Diagnostic Substance Manufacturing Veterans Health Administration prohibits the use of gray market items in their Medical Centers. Gray market items are considered to be items outside of the original equipment manufacturer s intended distribution channels. This notice is not a request for quotes; however, all responsible sources may submit a capability statement which shall be considered by the Government. All capability statements must be received by no later than 10:00 AM Eastern Standard Time on August 27, 2025. Responses to be submitted to Morgan Weeks, Contracting Officer at Morgan.Weeks1@va.gov. A determination by the Government not to compete this proposed contract based on responses to this notice is solely within the discretion of the Gove